Phase 2 Start
CGON: Phase2_Start: A Phase II Randomized Study of Reirradiation for Locally Recurrent Non-Small Cell Lung Cancer
December 18, 2026. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 18, 2026
- Company
- CG Oncology, Inc. (CGON)
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Start
Phase2_Start: A Phase II Randomized Study of Reirradiation for Locally Recurrent Non-Small Cell Lung Cancer
- Company
- CG Oncology, Inc. (CGON)